These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26976690)

  • 1. Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes.
    Clementi N; Criscuolo E; Cappelletti F; Burioni R; Clementi M; Mancini N
    Drug Discov Today; 2016 Apr; 21(4):682-91. PubMed ID: 26976690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Steps in Herpes Simplex Virus Infection Blocked by a Proteasome Inhibitor.
    Schneider SM; Pritchard SM; Wudiri GA; Trammell CE; Nicola AV
    mBio; 2019 May; 10(3):. PubMed ID: 31088925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Houttuynia cordata targets the beginning stage of herpes simplex virus infection.
    Hung PY; Ho BC; Lee SY; Chang SY; Kao CL; Lee SS; Lee CN
    PLoS One; 2015; 10(2):e0115475. PubMed ID: 25643242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Drugs to Treat Infections with Herpes Simplex Viruses-1 and -2.
    Sadowski LA; Upadhyay R; Greeley ZW; Margulies BJ
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34202050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyhydroxylated sulfated steroids derived from 5α-cholestanes as antiviral agents against herpes simplex virus.
    Pujol CA; Sepúlveda CS; Richmond V; Maier MS; Damonte EB
    Arch Virol; 2016 Jul; 161(7):1993-9. PubMed ID: 27101075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of herpes simplex virus type 1 entry by chloride channel inhibitors tamoxifen and NPPB.
    Zheng K; Chen M; Xiang Y; Ma K; Jin F; Wang X; Wang X; Wang S; Wang Y
    Biochem Biophys Res Commun; 2014 Apr; 446(4):990-6. PubMed ID: 24657267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic analogues of bovine bactenecin dodecapeptide reduce herpes simplex virus type 2 infectivity in mice.
    Shestakov A; Jenssen H; Hancock RE; Nordström I; Eriksson K
    Antiviral Res; 2013 Nov; 100(2):455-9. PubMed ID: 24012999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle.
    Criscuolo E; Clementi N; Mancini N; Burioni R; Miduri M; Castelli M; Clementi M
    Antiviral Res; 2018 Mar; 151():71-77. PubMed ID: 29357297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of herpes simplex virus infections in pediatric patients: current status and future needs.
    James SH; Whitley RJ
    Clin Pharmacol Ther; 2010 Nov; 88(5):720-4. PubMed ID: 20881952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro.
    Schuhmacher A; Reichling J; Schnitzler P
    Phytomedicine; 2003; 10(6-7):504-10. PubMed ID: 13678235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro.
    Nolkemper S; Reichling J; Stintzing FC; Carle R; Schnitzler P
    Planta Med; 2006 Dec; 72(15):1378-82. PubMed ID: 17091431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus type-1: replication, latency, reactivation and its antiviral targets.
    Pires de Mello CP; Bloom DC; Paixão IC
    Antivir Ther; 2016; 21(4):277-86. PubMed ID: 26726828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus resistance to acyclovir: clinical relevance.
    Pottage JC; Kessler HA
    Infect Agents Dis; 1995 Sep; 4(3):115-24. PubMed ID: 8548189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of myosin light chain kinase can be targeted for the development of new therapies against herpes simplex virus type-1 infection.
    Antoine TE; Shukla D
    Antivir Ther; 2014; 19(1):15-29. PubMed ID: 23813409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of an aqueous Pelargonium sidoides extract against herpesvirus.
    Schnitzler P; Schneider S; Stintzing FC; Carle R; Reichling J
    Phytomedicine; 2008 Dec; 15(12):1108-16. PubMed ID: 18691858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Herpes simplex virus types 1 and 2 (HSV-1 and HSV-2)].
    Thouvenot D; Najioullah F
    Rev Prat; 1999 Dec; 49(20):2203-7. PubMed ID: 10731803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of resveratrol on herpes simplex virus vaginal infection in the mouse.
    Docherty JJ; Fu MM; Hah JM; Sweet TJ; Faith SA; Booth T
    Antiviral Res; 2005 Sep; 67(3):155-62. PubMed ID: 16125258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antiviral activity of arbidol hydrochloride against herpes simplex virus type II (HSV-2) in a mouse model of vaginitis.
    Du Q; Gu Z; Leneva I; Jiang H; Li R; Deng L; Yang Z
    Int Immunopharmacol; 2019 Mar; 68():58-67. PubMed ID: 30612085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Herpes simplex virus activity of Bidens pilosa and Houttuynia cordata.
    Chiang LC; Chang JS; Chen CC; Ng LT; Lin CC
    Am J Chin Med; 2003; 31(3):355-62. PubMed ID: 12943167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genital herpes.
    Garland SM; Steben M
    Best Pract Res Clin Obstet Gynaecol; 2014 Oct; 28(7):1098-110. PubMed ID: 25153069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.